Nintedanib + Erythromycin Interaction
Unknowninteraction on record
Description
Concomitant use of P-gp and CYP3A4 inhibitors (e.g., erythromycin) with OFEV may increase exposure to nintedanib [see Clinical Pharmacology (12.3) ] .
Source: FDA drug label - nintedanib